Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma

NCT06211114 ·Status: RECRUITING ·Phase: PHASE2

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

NCT06363123 ·Status: RECRUITING

PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

NCT07175480 ·Status: RECRUITING ·Phase: PHASE2

Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases

NCT05129202 ·Status: COMPLETED

Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint Inhibitors

NCT05055908 ·Status: RECRUITING ·Phase: PHASE3

MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

NCT06912152 ·Status: RECRUITING ·Phase: PHASE1

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

NCT05780307 ·Status: RECRUITING ·Phase: PHASE1

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

NCT03967977 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms

NCT04766515 ·Status: RECRUITING

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

NCT06010875 ·Status: RECRUITING ·Phase: PHASE1

Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer

NCT03765190 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Phase I/II Study of SCTB39G in Advanced Solid Tumours

NCT07077252 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer

NCT06381895 ·Status: COMPLETED

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

NCT05862259 ·Status: RECRUITING

High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer

NCT03007875 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001

NCT06410092 ·Status: RECRUITING ·Phase: PHASE1

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

NCT06612840 ·Status: RECRUITING ·Phase: PHASE1

A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma

NCT04636515 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

NCT04137588 ·Status: UNKNOWN

A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

NCT03736330 ·Status: UNKNOWN ·Phase: PHASE2

A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC

NCT07178795 ·Status: RECRUITING ·Phase: PHASE3

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

NCT06208033 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

NCT07005336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer

NCT06519669 ·Status: TERMINATED ·Phase: NA

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

NCT05965856 ·Status: RECRUITING ·Phase: PHASE2